Pharmacists in Comerio, PR Accepting Medicare
8 Pharmacists found. Showing 1 - 8
 Pedro Romero Cruz, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 75 Calle Georgetti, Comerio, PR 00782 Phone: 787-875-2255 Fax: 787-875-2255 |
Dr. Carlos Stephen Martinez Cosme, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 18 Calle Georgetti, Comerio, PR 00782 Phone: 787-875-3375 |
 Tatiana Cruz, PHD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 23 Carr 778, Comerio, PR 00782 Phone: 787-616-9908 |
Gilmaris Virella Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Hc 2 Box 7240, Comerio, PR 00782 Phone: 787-970-8107 |
Maria A Gonzalez Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Bo Dona Elena, Hc-03 Box 7327, Comerio, PR 00782 Phone: 787-875-6141 |
William Garcia, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 85 Calle Georgetti, Comerio, PR 00782 Phone: 787-875-8265 Fax: 787-875-8265 |
Elba N Marrero Berrios, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 75 Calle Georgetti, Comerio, PR 00782 Phone: 787-875-2255 Fax: 787-875-2255 |
Mr. Luis A Fuentes Sr. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 40 Calle Georgetti, Comerio, PR 00782 Phone: 787-875-2121 Fax: 787-875-2245 |
News Archive
Illumina announces shipment of HiScanSQ system for research needs
Illumina, Inc. today announced shipment of HiScanSQ, the first instrument to integrate microarray analysis and next-generation sequencing in a modular design that can evolve with changing research needs.
UPCI scientists reveal how cancer cells hijack DNA repair pathways to stay alive
Research by scientists at the University of Pittsburgh Cancer Institute has revealed how cancer cells hijack DNA repair pathways to prevent telomeres, the endcaps of chromosomes, from shortening, thus allowing the tumor to spread. The findings are published today in the journal Cell Reports.
Recommendations for safe and effective testing of artificial pancreas systems in real-life settings
Diabetes experts at a meeting convened by the U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH) took the next step in advancing efforts toward the development of an artificial pancreas: putting forth clinical recommendations to ensure the safe and effective testing of artificial pancreas technology in real-life situations.
OxThera announces initiation of Oxabact clinical study in Primary Hyperoxaluria
OxThera AB, a Stockholm-based privately-held biopharmaceutical company, today announced that it has initiated a clinical study in Primary Hyperoxaluria. This announcement bolsters the Company's position as a leader in developing therapies for hyperoxaluria, a debilitating condition that, if untreated, leads to kidney damage and end-stage renal disease.
Immunotherapy and chemotherapy combined, slows tumor progression and extends survival of patients with glioblastoma multiforme
Researchers at Cedars-Sinai's Maxine Dunitz Neurosurgical Institute have found that the combination of immunotherapy and chemotherapy significantly slowed tumor progression and extended survival of patients with glioblastoma multiforme (GBM).
› Verified 2 days ago